Lasilix

Furosemide, the active ingredient in Lasilix, is a loop diuretic presented as an injectable solution for intramuscular and intravenous use. It is employed to manage fluid overload in conditions such as congestive heart failure, hepatic cirrhosis, renal disease, and hypertension.

GNH USA supplies Lasilix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lasilix (furosemide) acts on the renal loop of Henle to promote diuresis in several fluid‑retention disorders.

- Edema associated with congestive heart failure: reduces excess fluid and eases breathlessness. - Edema due to hepatic cirrhosis: facilitates removal of ascitic fluid and improves abdominal distension. - Edema due to renal disease: enhances urinary output to control fluid accumulation. - Hypertension: lowers blood pressure by decreasing plasma volume.

Lasilix may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Increased urinary frequency: patients notice a marked rise in urine output. - Electrolyte disturbances (e.g., hypokalemia, hyponatremia): may cause muscle cramps or weakness. - Dizziness or light‑headedness: often related to volume depletion. - Headache: transient and usually mild. - Dehydration: due to excessive fluid loss. - Hypotension: especially when standing.

Serious or Rare Side Effects: - Ototoxicity: hearing loss or tinnitus, particularly with high‑dose IV therapy. - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Acute renal failure: abrupt decline in kidney function. - Significant electrolyte imbalance: can lead to cardiac arrhythmias. - Thrombocytopenia: low platelet count causing bleeding risk. - Pancreatitis: inflammation of the pancreas presenting with abdominal pain.

Before using Lasilix, clinicians should consider several safety measures.

- Monitor electrolytes: check serum potassium, sodium, and magnesium regularly. - Assess renal function: evaluate creatinine and eGFR prior to initiation and during therapy. - Adjust dose in hepatic impairment: reduced clearance may increase toxicity. - Use cautiously in hypotensive patients: avoid rapid over‑diuresis. - Avoid in known hypersensitivity to furosemide or sulfonamides. - Store at ambient temperature: keep in original container, protect from moisture and light.

Lasilix can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - NSAIDs: may blunt diuretic response and worsen renal function. - Aminoglycoside antibiotics: increased risk of ototoxicity. - Lithium: furosemide reduces lithium clearance, raising toxicity risk. - ACE inhibitors or ARBs: combined use can cause profound hypotension and renal impairment.

Moderate Interactions (Monitor Closely): - Other loop diuretics: additive diuretic effect may lead to severe dehydration. - Thiazide diuretics: combined therapy heightens electrolyte loss. - Corticosteroids: may enhance sodium loss. - Anticholinergic agents: can reduce urinary output. - Antihypertensive agents: monitor blood pressure for excessive drops.